News
1d
Medpage Today on MSNOnce-Weekly Basal Insulin Non-Inferior to Several Daily Options in Type 2 DiabetesCHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the ...
One-year data suggest allogeneic stem cell-derived islet-cell therapy could become a future option for those with type 1 ...
CHICAGO -- An investigational allogeneic stem cell-derived islet-cell therapy helped almost all patients with type 1 diabetes ...
A cell therapy developed by Vertex Pharma has allowed 10 of 12 patients with type 1 diabetes to control their blood sugar ...
1hon MSN
A revolutionary stem cell therapy has helped Amanda Smith ditch insulin injections for good, offering new hope to diabetics ...
In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to ...
One of the first brain cells shown to make insulin is the neurogliaform cell. These live in a brain area important for ...
Inhaled insulin is an “important alternative” to injected rapid-acting analog insulin for children and teens with diabetes, ...
Amanda Smith has kicked insulin to the curb in what experts are calling a milestone in the fight against Type 1 diabetes.
Insulin resistance detected by routine triglyceride-glucose (TyG) index can flag people with early Alzheimer's who are four ...
A new study published in the Journal of Ultrasound in Medicine ultrasound of one's thigh or shoulder muscle can help detect ...
Good morning! Today, we get deeper into the ousting of Nicole Verdun at the FDA, see promise from Vertex’s cell therapy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results